Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 12:16 AM
Ignite Modification Date:
2025-12-25 @ 12:16 AM
NCT ID:
NCT03423758
Eligibility Criteria:
Inclusion Criteria:
1. For patients with PXF:
* Patients with confirmed pseudoexfoliation syndrome (exfoliation glaucoma / pseudoexfoliation of the lens) in the medical history
* Informed consent
* Age 50 years or more
2. For patients with PACG:
* Patients with confirmed acute primary angle closure (PAC) or primary angle closure glaucoma (PACG) in the medical history
* Informed consent
* Age 21 years or more
3. For healthy controls:
* No evidence of PXF, glaucoma or uveitis during clinical examination or in the medical history
* No evidence of major ocular disease such as diabetic retinopathy, age related macular degeneration or conditions with genetic background during clinical examination or in the medical history
* Age more than 60 years
* Informed consent
4. For patients with POAG:
* Patients with confirmed primary open angle glaucoma (POAG)
* No evidence of exfoliation glaucoma / pseudoexfoliation of the lens or pigment glaucoma
* Informed consent
* Age 30 or more
Exclusion Criteria:
* Patients and subjects will be excluded if one or more of the following criteria apply:
* Neovascular glaucoma
* Active or history of uveitis
* Secondary angle closure such as neovascular glaucoma or uveitis/inflammatory eye disease
* Inability to give informed consent
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
21 Years
Maximum Age:
105 Years
Study:
NCT03423758
Study Brief:
Protocol Section:
NCT03423758